Magic Cure Or An Expensive Trip? Psychedelics Explained

Last week, the Therapeutic Goods Administration changed the classification of Psilocybin and MDMA to allow psychiatrists to prescribe them for use in treating some mental health disorders. But with this change comes questions. Who will benefit from their use? Who will be eligible? In today's episode of The Quicky, we speak to professionals to break down psychedelics for the treatment of mental health issues and whether this move really does open up the door to new treatments that could end the suffering of thousands. We also speak to a woman who lost her husband who's life may have been saved if he had access to these drugs. Subscribe to Mamamia GET IN TOUCH Feedback? We’re listening! Call the pod phone on 02 8999 9386 or email us at [email protected] CONTACT US Got a topic you'd like us to cover? Send us an email at [email protected] CREDITS Host: Claire Murphy With thanks to: Tania De Jong - Founder of Mind Medicine Australia Dr Vince Polito - Senior Research Fellow at the School of Psychological Sciences at the Biomolecular Discovery Research Centre at Macquarie University Vanessa and Franco - thank you for sharing your story Producer: Claire Murphy Executive Producer: Kally Borg Audio Producer: Thom Lion Become a Mamamia subscriber: https://www.mamamia.com.au/subscribe See omnystudio.com/listener for privacy information.